Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $114.9000 (-0.55%) ($114.0300 - $115.8900) on Thu. Jun. 17, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.06% (three month average) | RSI | 62 | Latest Price | $114.9000(-0.55%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.2% a day on average for past five trading days. | Weekly Trend | ABBV advances 1.4% a week on average for past two weeks. | Market Behavior | Rotation from value to growth for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(45%) SPLV(35%) VYM(32%) XLP(32%) DIA(31%) | Factors Impacting ABBV price | ABBV will decline at least -0.53% in a week (0% probabilities). VIXM(-21%) UUP(-10%) VXX(-2%) TLT(-2%) KWEB(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.53% (StdDev 1.06%) | Hourly BBV | -0.6 () | Intraday Trend | -0.4% | | | |
|
5 Day Moving Average | $115.42(-0.45%) | 10 Day Moving Average | $114.57(0.29%) | 20 Day Moving Average | $114.24(0.58%) | To recent high | -2% | To recent low | 11.5% | Market Cap | $202.716b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |